Incorporating recipient choice in kidney transplantation

Journal of the American Society of Nephrology

Volumn 15, Issue 6, 2004, Pages 1656-1663

  Su, Xuanming ^a   Zenios, Stefanos A ^a   Chertow, Glenn M ^b,c  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ALGORITHM; ARTICLE; COST EFFECTIVENESS ANALYSIS; GRAFT FAILURE; HLA TYPING; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MONTE CARLO METHOD; MORTALITY; POLICY; PREDICTION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SIMULATION;

EID: 2542504500     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000127866.34592.60     Document Type: Article

References (15)

1. Gaston RS, Danovitch GM, Adams PL, Wynn JJ, Merion RM, Deierhoi MH, Metzger RA, Cecka JM, Harmon WE, Leichtman AB, Spital A, Blumberg E, Herzog CA, Wolfe RA, Tyan DB, Roberts J, Rohrer R, Port FK, Delmonico FL: The report of a national conference on the wait list for kidney transplantation. Am J Transplant 3: 775-785, 2003
2. Zenios SA, Wein LM, Chertow GM: Evidence-based organ allocation. Am J Med 107: 52-61, 1999
3. UNOS: 2002 Annual Report of the US Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant Data 1992-2001, Rockville, MD, United Network for Organ Sharing, 2003
4. US Renal Data System. USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institutes of Digestive and Kidney Diseases, 2002
5. Cox DR: Regression models and life tables. J R Stat Soc 74: 187-220, 1972
6. Chertow GM, Milford EL, Mackenzie HS, Brenner BM: Antigen-independent determinants of cadaveric kidney transplant failure. JAMA 276: 1732-1736, 1996
7. Laupacis A, Keown P, Pus N, Krueger H, Ferguson B, Wong C, Muirhead N: A study of the quality of life and cost-utility of renal transplantation. Kidney Int 50: 235-242, 1996
8. de Wit GA, Merkus MP, Krediet RT, de Charro FT: Health profiles and health preferences of dialysis patients. Nephrol Dial Transplant 17: 86-92, 2002
9. Pastan S, Bailey J: Dialysis therapy. N Engl J Med 338: 1428-1437, 1998
10. Schweitzer EJ, Wiland A, Evans D, Novak M, Connemy I, Norris L, Colonna JO, Philosophe B, Farney AC, Jarrell BE, Bartlett ST: The shrinking renal replacement therapy "breakeven" point. Transplantation 66: 1702-1708, 1998
11. Ubel PA, Hirth RA, Chernew ME, Fendrick AM. What is the price of life and why doesn't it increase at the rate of inflation? Arch Intern Med 163: 1637-1641, 2003
12. Neumann PJ, Goldie SJ, Weinstein MC: Preference-based measures in economic evaluation in health care. Annu Rev Public Health 21: 587-611, 2000
13. Meier-Kriesche HU, Kaplan B: Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: A paired donor kidney analysis. Transplantation 74: 1377-1381, 2002
14. Cho YW. Expanded criteria donors. In: Clinical Transplants, edited by Cecka JM, Terasaki PI, Los Angeles, UCLA Tissue Typing Laboratory, 1998, pp 421-436
15. Price DA, Owen WF Jr: African-Americans on maintenance dialysis: A review of racial differences in incidence, treatment, and survival. Adv Ren Replace Ther 4: 3-12, 1997